Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies

Magnetic Resonance in Medicine

Volumn 36, Issue 6, 1996, Pages 887-892

  Koutcher, Jason A ^a   Alfieri, Alan A ^b   Matei, Cornelia ^a   Meyer, Kristen L ^a   Street, James C ^a   Martin, Daniel S ^a,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c Catholic Medical Center   (United States)

Author keywords

6 aminonicotinamide; 6 phosphogluconate; NMR; pentose phosphate pathway

Indexed keywords

CHEMICAL SHIFT; IMAGING TECHNIQUES; MAMMALS; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RADIATION;

6-AMINONICOTINAMIDE; 6-PHOSPHOGLUCONATE; AFTER-TREATMENT; CHEMICAL SHIFT IMAGING; MAMMARY CARCINOMA; PENTOSE PHOSPHATE PATHWAY; RADIATION-INDUCED; SPECTRAL DATA;

TUMORS;

6 AMINONICOTINAMIDE; CREATINE PHOSPHATE; PENTOSE PHOSPHATE; PHOSPHATE; RADIOSENSITIZING AGENT;

ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER MODEL; CANCER RADIOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; NONHUMAN; PHOSPHATE METABOLISM; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; RADIATION DOSE; RADIOSENSITIZATION; TREATMENT OUTCOME; TUMOR GROWTH;

EID: 0029950473     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/mrm.1910360611     Document Type: Article

References (32)

1. V. T. De Vita, in "Principles of Chemotherapy in Cancer: Principles and Practice of Oncology" (V. T. DeVita, S. Hellman, S. A. Rosenberg, Eds.), 4th ed., p. 277, J.B. Lippincott Co., Philadelphia, 1993.
2. J. M. Brown, E. J. Hall, D. G. Hirst, T. J. Kinsella, M. M. Kligerman, J. B. Mitchell, E. J. Travis, F. Valeriote, Chemical modification of radiation and chemotherapy. Am. J. Clin. Oncol. 11, 288-303 (1988).
3. M. Karlsson, H. Nystrom, H. Svensson, Electron beam characteristics of the 50 MeV racetrack microtron. Med. Phys. 19, 307-315 (1992).
4. S. A. Leibel, R. Heimann, G. J. Kutcher, M. J. Zelefsky, C. M. Burman, E. Melian, J. P. Orazem, R. Mohan, T. J. LoSasso, Y. C. Lo, J. A. Wiseberg, D. C. Chapman, C. C. Ling, Z. Fuks. Three dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study. Int. J. Radiat. Oncol. Biol. Phys. 28, 55-65 (1993).
5. J. E. Biaglow, M. E. Varnes, E. P. Clark, E. R. Epp, The role of thiols in cellular response to radiation and drugs. Radiat. Res. 95, 437-455 (1983).
6. W. Roberts, M. Kartha, A. L. Sagone, Effect of irradiation on the hexose monophosphate shunt pathway of human lymphocytes. Radiat. Res. 79, 601-610 (1979).
7. M. P. Westerman, N. Wald, M. Diloy-Puray, Irradiation shortens the survival time of red cells deficient in glucose-6-phosphate dehydrogenase. Radiat. Res. 81, 473-477 (1980).
8. N. A. Berger, D. M. Catino, T. J. Vietti, Synergistic antileukemic effect of BAN and 1,3 Bis (2-chloroethyl)-1-nitrosourea on L1210 cells in vitro and in vivo. Cancer Res. 42, 4382-4386 (1982).
9. M. Varnes, Inhibition of pentose cycle of A549 cells by 6AN: consequences for aerobic and hypoxic radiation response and for radiosensitizer action. NCI Monograph 6, 199-203 (1988).
10. 31P NMR investigation of effect of 6-aminonicotinamide on metabolism of RIF-1 tumour cells in vitro. J. Biol. Chem. 271, 4113-4119 (1996).
11. D. Ballon, U. Mahmood, A. Jakubowski, J. A. Koutcher, Resolution enhanced NMR spectroscopy in biological systems via magnetic susceptibility matched sample immersion chambers. Magn. Reson. Med. 30, 754-758 (1993).
12. T. R. Brown, B. M. Kincaid, K. Ugurbil, NMR chemical shift imaging in 3 dimensions. Proc. Natl. Acad. Sci. USA 79, 3523-3526 (1982).
13. 31P NMR spectroscopy. Int. J. Radiat. Oncol. Biol. Phys. 13, 1851-1855 (1987).
14. R. L. Stolfi, D. S. Martin, R. A. Fugmann, Spontaneous murine mammary adenocarcinoma: model system for evaluation of combined methods of therapy. Cancer Chemother. Rep. 55, 239-251 (1971).
15. D. S. Martin, R. A. Fugmann, R. L. Stolfi, P. E. Hayworth, Solid tumor animal model therapeutically predictive for human breast cancer. Cancer Chemother. Rep. 5, 89-109 (1975).
16. J. A. Koutcher, A. A. Alfieri, R. L. Stolfi, M. L. Devitt, J. R. Colofiore, D. S. Martin, Potentiation of a 3-drug chemotherapy regimen by radiation. Cancer Res. 53, 3518-3523 (1993).
17. J. C. Street, U. Mahmood, C. Matei, J. A. Koutcher, In-vivo and In-vitro studies of cyclophosphamide chemotherapy in a mouse mammary carcinoma by 31 P NMR spectrospcopy. NMR Biomed. 8, 149-158 (1995).
18. D. B. Vigneron, S. J. Nelson, J. Murphy-Boesch, D. A. C. Kelly, H. B. Kessler, T. R. Brown, J. S. Taylor, Chemical shift imaging of human brain: axial, sagittal and coronal P-31 metabolite images. Radiology 177, 643-649 (1990).
19. D. Hunting, B. Gowans, J. F. Henderson, Effects of 6-aminonicotinamide on cell growth. Poly (ADP-ribose) synthesis and nucleotide metabolism. Biochem. Pharmacol. 34, 3999-4003 (1985).
20. H. A. Krebs, L. V. Eggleston, The regulation of the pentose phosphate cycle in rat liver, in "Advances in Enzyme Regulation" (G. Weber, Ed.), vol. 12, pp. 421-434, Pergamon Press, New York, 1974.
21. D. S. Martin, M. M. Kligerman, R. A. Fugmann, Radiotherapy and adjuvant combination chemotherapy (6-aminonicotinamide and 6-mercaptopurine). Cancer Res. 18, 893-896 (1958).
22. 31P MR spectroscopic study. Biochem. Biophys. Res. Commun. 164, 947-953 (1989).
23. U. Mahmood, J. C. Street, C. M. Matei, D. Ballon, D. S. Martin, J. A. Koutcher, In vivo detection of pentose phosphate pathway blockade secondary to biochemical modulation. NMR Biomed., in press.
24. J. A. Koutcher, A. A. Alfieri, M. L. Devitt, J. G. Rhee, A. B. Kornblith, U. Mahmood, T. D. Merchant, D. Cowburn, Quantitative changes in tumor metabolism, partial pressure of oxygen nad radiobiological oxygenation status post radiation. Cancer Res. 52, 4620-4627 (1992).
25. 31P NMR spectroscopy. Cancer Res. 54, 4885-4891 (1994).
26. 31P NMR measurements of metabolic changes post radiation. Cancer Res. 55, 1248-1254 (1995).
27. 31P NMR Study of response of a mammary carcinoma to chemotherapy, in "Proc, SMR, 3rd Annual Meeting, 1995," p. 1687.
28. G. G. Steel, M. J. Peckham, Exploitable mechanisms in combined radiotherapy chemotherapy: the concept of additivity. Int. J. Radiat. Oncol. Biol. Phys. 5, 85-91 (1979).
29. D. W. Siemann, S. M. Sutherland, The interaction between adriamycin and radiation in a solid murine tumor. Radiat. Res. 83, 345-359 (1980).
30. J. E. Biaglow, B. Jacobson, C. L. Greenstock, J. Raleigh, Effect of nitrobenzene derivatives on electron transfer in cellular and chemical models. Mol. Pharmacol. 13, 269-282 (1977).
31. O. W. Griffiths, M. E. Anderson, A. Meister, Inhibition of glutathione biosynthesis by prothionine sulfoximine (S-n-propyl homocysteine sulfoxime), a selective inhibitor of g-glutamylcysteine synthetase. J. Biol. Chem. 254, 1206-1210 (1979).
32. F. P. Herter, S. G. Weissman, H. G. Thompson, G. Hyman, D. S. Martin, Clinical experience with 6 aminonicotinamide. Cancer Res. 21, 31-37 (1961).